We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-17.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.26B
AUM Growth
-$464M
Cap. Flow
+$97.5M
Cap. Flow %
4.32%
Top 10 Hldgs %
30.92%
Holding
158
New
12
Increased
35
Reduced
23
Closed
24

Top Buys

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$50.6M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$28.2M
3
ZGNX
Zogenix, Inc.
ZGNX
+$21.7M
4
TLND
Talend S.A. American Depositary Shares
TLND
+$18.7M
5
TWLO icon
Twilio
TWLO
+$17.9M

Top Sells

Rank Stock Value
1
ANAB icon
AnaptysBio
ANAB
+$26.2M
2
ECYT
Endocyte, Inc. Common Stock
ECYT
+$23.3M
3
MIC
Macquarie Infrastructure Holdings, LLC
MIC
+$19.7M
4
SLDB icon
Solid Biosciences
SLDB
+$18.9M
5
SNA icon
Snap-on
SNA
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 42.75%
2 Technology 23.08%
3 Consumer Discretionary 10.05%
4 Industrials 6.38%
5 Communication Services 2.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma A/S
ASND
$16.5B
$106M 4.71%
1,698,648
+153,748
+10% +$9.66M
SRPT icon
2
Sarepta Therapeutics
SRPT
$1.64B
$92.2M 4.08%
845,168
+225,168
+36% +$28.2M
SAGE
3
DELISTED
Sage Therapeutics
SAGE
$89.7M 3.97%
936,000
+442,000
+89% +$50.6M
SEND
4
DELISTED
SendGrid, Inc.
SEND
$77.4M 3.43%
1,793,000
-175,653
-9% -$6.76M
ZGNX
5
DELISTED
Zogenix, Inc.
ZGNX
$62.5M 2.76%
1,713,000
+529,208
+45% +$21.7M
SPLK
6
DELISTED
Splunk Inc
SPLK
$59.1M 2.62%
564,000
+111,000
+25% +$11.2M
PANW icon
7
Palo Alto Networks
PANW
$265B
$56.7M 2.51%
1,806,000
+558,000
+45% +$17.4M
TTD icon
8
Trade Desk
TTD
$8.59B
$55.8M 2.47%
4,810,000
+1,210,000
+34% +$15.1M
LOW icon
9
Lowe's Companies
LOW
$118B
$52.2M 2.31%
565,000
– –
W icon
10
Wayfair
W
$11.9B
$46.4M 2.05%
514,777
+114,777
+29% +$12.1M
XPO icon
11
XPO
XPO
$23.4B
$44.9M 1.99%
2,278,418
– –
HUBS icon
12
HubSpot
HUBS
$11.9B
$44M 1.95%
350,000
– –
AIMT
13
DELISTED
Aimmune Therapeutics
AIMT
$41.6M 1.84%
1,739,000
– –
FIVN icon
14
FIVE9
FIVN
$2.12B
$39.1M 1.73%
894,000
– –
WCN
15
Waste Connections
WCN
$41.9B
$38.4M 1.7%
517,000
– –
LOXO
16
DELISTED
Loxo Oncology, Inc
LOXO
$38.4M 1.7%
274,000
+45,000
+20% +$6.83M
COLL icon
17
Collegium Pharmaceutical
COLL
$1.17B
$37.9M 1.68%
2,207,610
– –
VRTX icon
18
Vertex Pharmaceuticals
VRTX
$122B
$37M 1.64%
223,000
-90,000
-29% -$15.6M
MYOV
19
DELISTED
Myovant Sciences Ltd.
MYOV
$36.2M 1.6%
2,204,708
+89,708
+4% +$1.77M
VRNS icon
20
Varonis Systems
VRNS
$4.58B
$34.5M 1.53%
1,956,000
-231,000
-11% -$4.56M
XIFR
21
XPLR Infrastructure LP
XIFR
$1.12B
$34.1M 1.51%
791,000
-8,500
-1% -$387K
CCI icon
22
Crown Castle
CCI
$33.4B
$32.6M 1.44%
300,000
-5,000
-2% -$549K
LII icon
23
Lennox International
LII
$14.5B
$31.5M 1.4%
144,000
+26,000
+22% +$5.49M
LRCX icon
24
Lam Research
LRCX
$372B
$30.9M 1.37%
2,270,000
– –
INST
25
DELISTED
Instructure, Inc.
INST
$30.2M 1.34%
805,796
– –
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Eventide Asset Management held 158 positions worth $2.26B, down 17% from $2.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Eventide Asset Management deployed $97.5M of net new capital in Q4 2018, opening 12 new positions and adding to 35 existing holdings. Its largest new stake was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Macquarie Infrastructure Holdings, LLC, an estimated $19.7M trimmed.

  • Eventide Asset Management's largest Q4 2018 buy was Talend S.A. American Depositary Shares: 388,033 shares worth $14.4M.
  • Eventide Asset Management added most to Sage Therapeutics in Q4 2018, an estimated $50.6M increase.
  • Eventide Asset Management's biggest Q4 2018 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $19.7M.
  • Eventide Asset Management fully exited AnaptysBio in Q4 2018, selling an estimated $26.2M.
  • Eventide Asset Management's ten largest holdings make up 31% of its $2.26B portfolio in Q4 2018.
  • Eventide Asset Management opened 12 new positions and closed 24 in Q4 2018.
  • Eventide Asset Management's portfolio value fell 17% quarter-over-quarter to $2.26B.

Based on Eventide Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.